Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

iShares ESG Aware 60/40 Balanced Allocation ETF (NY:EAOR)

35.08 +0.03 (+0.09%)
Official Closing Price Updated: 4:10 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,499
Open 35.18
Bid (Size) 17.58 (2)
Ask (Size) 52.74 (2)
Prev. Close 35.05
Today's Range 35.08 - 35.18
52wk Range 28.94 - 35.25
Shares Outstanding N/A
Dividend Yield 2.94%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report
Via Stocktwits
Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update
Via Stocktwits

Performance

YTD
+12.1%
+12.1%
1 Month
+3.4%
+3.4%
3 Month
+5.3%
+5.3%
6 Month
+14.3%
+14.3%
1 Year
+9.4%
+9.4%

More News

Read More
Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement
Via Stocktwits
Topics Government
Uber Reportedly Expects Non-Restaurant Deliveries To Surge Faster Than Previously Expected
Via Stocktwits
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp
Via Stocktwits
Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease
Via Stocktwits
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues
Via Stocktwits
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study
Via Stocktwits
Oklo Stock Continues To Be The Talk Of The Town After Gaining 87% In A Month – Here’s How Retail Investors Responded
Via Stocktwits
Cracker Barrel In Spotlight After Slew Of Price Target Cuts: Citi Says Q1 Began In A ‘Deep Traffic Hole’ Post Logo Change
Via Stocktwits
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite
Via Stocktwits
Topics Government
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event
Via Stocktwits
Topics Artificial Intelligence
Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside
Via Stocktwits
Topics Death
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
Via Stocktwits
This Aerospace Stock Witnessed A 700% Explosion In Retail Chatter On Stocktwits – More Details Inside
Via Stocktwits
IONS Stock Soars 34% To Hit February 2021 Highs After Medicine Shows Positive Effect On Elevated Triglyceride Levels In Late-Stage Studies
Via Stocktwits
Soleno Therapeutics Stock Slumps After Scorpion Capital Reveals Short Position: But Retail’s Not Pessimistic Yet
Via Stocktwits
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversold
Via Stocktwits
Sarepta Draws Wall Street Ire After Third Patient Death This Year: Analyst Says ‘Deeply Concerning’ The Incident Wasn’t Reported Earlier
Via Stocktwits
Sarepta Just Got A Good Restructuring Deal For $700M Debt, But Stock Tumbles 7% – Here’s Why
Via Stocktwits
PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided
Via Stocktwits
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About Elevidys
Via Stocktwits
Topics Death
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
Via Stocktwits
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results
Via Stocktwits

Frequently Asked Questions

Is iShares ESG Aware 60/40 Balanced Allocation ETF publicly traded?
Yes, iShares ESG Aware 60/40 Balanced Allocation ETF is publicly traded.
What exchange does iShares ESG Aware 60/40 Balanced Allocation ETF trade on?
iShares ESG Aware 60/40 Balanced Allocation ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares ESG Aware 60/40 Balanced Allocation ETF?
The ticker symbol for iShares ESG Aware 60/40 Balanced Allocation ETF is EAOR on the New York Stock Exchange
What is the current price of iShares ESG Aware 60/40 Balanced Allocation ETF?
The current price of iShares ESG Aware 60/40 Balanced Allocation ETF is 35.08
When was iShares ESG Aware 60/40 Balanced Allocation ETF last traded?
The last trade of iShares ESG Aware 60/40 Balanced Allocation ETF was at 10/03/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.